To identify predictors of symptomatic urinary tract infection (UTI) after 20 weeks' gestation.
Urinary tract infections (UTIs) are common in pregnancy and have been associated with preterm delivery and low birth weight. [1] [2] [3] Lower UTIs in the mother are more likely to progress to pyelonephritis during pregnancy, and pyelonephritis can result in sepsis and acute adult respiratory distress syndrome. 4, 5 In 1960, Kass 6 demonstrated that detection and treatment of asymptomatic bacteriuria (ASB) in pregnancy could diminish the likelihood of progression to symptomatic UTI. This was followed by various cohort studies describing the epidemiology of UTIs during pregnancy. 3,6 -16 These studies were limited by the breadth of risk factors explored and their statistical methodology. Thus, we conducted this study to identify demographic, behavioral, and medical history factors during and before pregnancy that are predictive of a symptomatic UTI in pregnancy after 20 weeks' gestation. Of particular interest was the identification of risk factors for pyelonephritis and separation of the correlated effects of black race and sickle cell hemoglobinopathies.
MATERIALS AND METHODS
A retrospective cohort was assembled of deliveries at three central North Carolina hospitals from 1990 to 1993: University of North Carolina Hospitals (UNCH), Duke University Medical Center (DUMC), and Durham Regional Hospital (DRH). Study details are published elsewhere. 17 Briefly, computerized obstetrics databases were analyzed and supplemented with medical chart abstracts. The original sources for all variables were routine patient questionnaires administered at the first or second prenatal visit by each clinic and medical charts maintained by the clinicians. A subset of charts was compared with the computerized data for validation. 17 Approval from human subjects was received from all participating hospitals.
Of the 9215 pregnancies initially identified, 1178 (13%) were excluded for pre-existing medical conditions with known associations with UTI (diabetes before pregnancy, 18, 19 positive HIV status, 20, 21 and structural abnormalities of the urinary tract), lack of prenatal care, and/or race other than black or white due to too few observations for analysis. Additional pregnancies were excluded due to missing gestational age (617 pregnancies), recorded gestational age at delivery of Ͻ20 weeks (8 pregnancies), continuous prophylactic antibiotics prescribed before 20 weeks' gestation (8 pregnancies), and unclear UTI dates (1 pregnancy). The final cohort consisted of 7403 pregnancies, which represented 6493 women. Multifetal gestations were treated as one pregnancy.
A symptomatic UTI was defined as (1) a clinical diagnosis of cystitis, UTI, or pyelonephritis as recorded on the medical chart (90% to 95% of the cases) or (2) a urine culture bacteria count of Ն100,000/ml (5% to 10% of the cases). Symptomatic infections diagnosed after 20 weeks' gestation and before delivery were the outcomes of interest. No restriction was made as to species of infecting organism. If two diagnoses were made within 3 weeks of one another and had the same or unknown infecting organism, only the first diagnosis was analyzed, with the second considered a relapse or a persistent infection. The screening protocols for ASB after the first prenatal care visit were as follows: dipstick tests at each visit at UNCH and urinalysis at 28 to 30 weeks' gestation at the health departments; no formal protocol existed at DUMC. Because the UNCH database did not contain the date of diagnoses, the charts of all UNCH deliveries coded as having had an antepartum UTI, sexually transmitted disease (STD), or vaginal infection were reviewed to obtain the diagnosis date needed for classification. Unclear UTI data from any of the hospitals were corroborated or corrected by chart reviews.
Predictors of interest included race; sickle cell disease or trait versus normal hemoglobin; maternal age; maternal employment outside the home; marital status; maternal education; gravidity; alcohol, cigarette smoking, and illicit drug use (using self-reports and clinic toxicology reports, excludes marijuana) during pregnancy; public/private prenatal clinic (classification represents the overall clinic clientele); hospital of delivery; pre-pregnancy history of UTI, STD, and chronic hypertension; and antepartum diagnosis during the first 20 weeks of a UTI, STD, and vaginal infection.
Risk factor prevalences were calculated by hospital, by race, and in total. Unadjusted cumulative incidence odds ratios (ORs) of UTI and 95% confidence intervals (CIs) were computed for each potential predictor. Unconditional logistic regression was conducted to simultaneously evaluate each potential predictor and control for hospital of delivery. Models were fit to predict diagnoses after 20 weeks' gestation of (1) any symptomatic UTI, (2) any UTI regardless of symptoms, which added 17 ASB cases, (3) cystitis alone, and (4) pyelonephritis alone. (Only the first and fourth models are displayed.) For all but the pyelonephritis model, potential interaction terms relative to hospital and race were initially identified from stratified analyses using Breslow-Day tests with p values of Ͻ0.15 as the selection criteria. These interactions were retained in subsequent models as necessary according to a step-wise procedure based on a p value of Ͻ0.15. Due to the relatively small number of pyelonephritis cases (Ͻ50), we restricted the number of explanatory variables to 5 to 10 variables 22 and did not evaluate interactions. The final models, as developed with SAS software (SAS Institute, Cary, NC), were rerun using methods for generalized estimating equations 23, 24 through SUDAAN software (Research Triangle Institute, Research Triangle Park, NC) to account for the dependence of multiple pregnancies from the same women. Only the SUDAAN results are reported here. Lastly, population-attributable fractions were calculated from the adjusted ratio estimates. 25 These percentages indicated which factors, after incorporation of the exposure prevalence, were important from a broader population perspective.
RESULTS
Overall, the pregnancies studied were evenly divided by race (Table 1) , half of the mothers were married, and half had completed Ն12 years of education. Mothers delivering at DUMC/DRH were mostly black (62%), more than half were unmarried (56%), and most attended public clinics for prenatal care (61%) (data not shown by hospital). Mothers delivering at UNCH were more often white (65%), married (61%), and tended to be older (38% over age 30). Mothers reported drinking alcohol and smoking during 15% and 20% of pregnancies, respectively (Table 1) . Pre-pregnancy medical conditions were reported more often among the deliveries from UNCH than DUMC/DRH (data not shown). Within each facility, black women more often reported a pre-pregnancy history of STDs.
The cumulative incidence of UTI (diagnosed after prenatal care initiation) was greater after 20 weeks' gestation (4.2%) than during the first 20 weeks of pregnancy (1.4%) ( Table 2) , and this held true when stratified by hospital and race. Note, however, that these two time periods are not necessarily identical in length, due to differing gestational ages at prenatal care entry and delivery. Thus, the incidence rates are not directly comparable. Cystitis was more frequently diagnosed than pyelonephritis in all medical facilities and time peri- PNC, prenatal care. ‫ء‬Includes asymptomatic bacteriuria. †Percentage excludes n ϭ 12 women with unknown bacteriuria status (including contaminated samples) and n ϭ 11 women on antibiotics at first visit; of these, 12 were white and 11 were African-American. All delivered at UNCH. ‡Prevalence figures for bacteriuria. §Numbers do not add up to total number of pregnancies with positive history due to multiple infections in some women.
ods displayed. The incidence of UTI was higher at UNCH than at DUMC/DRH, except for pyelonephritis, which was diagnosed with equal frequency. The incidence of UTI after 20 weeks' gestation was higher among blacks than whites. The clinics serving both public and private patients had higher rates of cystitis (7.7%) than exclusively public (4.2%) or exclusively private clinics (1.4%).
After adjustment for all factors simultaneously, the factors associated with at least twice the likelihood of symptomatic UTIs after 20 weeks' gestation were: UTIs both before pregnancy and during the first 20 weeks of pregnancy, location of care other than private clinics, and, for white women, a pre-pregnancy history of chlamydia (Table  3) . Pyelonephritis during the first 20 weeks of pregnancy had the largest risk estimate (cumulative incidence OR ϭ 6.0, 95% CI of 1.4 -25.4), followed by bacteriuria at the first prenatal visit and cystitis during the first 20 weeks of gestation with risk estimates of 4.1 to 5.3 among the UNCH deliveries. Attributable fractions of Ͼ5% were found for a pre-pregnancy history of UTI (6.4%) and black race (18.6%) (data not shown). Logistic regressions (1) restricted to cystitis diagnoses after 20 weeks' gestation, and (2) including ASB episodes after 20 weeks' gestation both produced associations of very similar magnitude.
The strongest predictor of pyelonephritis after 20 weeks' gestation (Table 4 ) was a diagnosis of UTI during the first 20 weeks of pregnancy (OR ϭ 5.3, 95% CI of 2.6 -11.0). All factors in the final model had ORs of Ն1.6 (sickle cell hemoglobinopathy, location of care other than a private clinic, illicit drug use, pre-pregnancy history of chlamydia, unmarried, and Յ12 years of education). Attributable fractions of Ͼ5% were found for UTIs during the first 20 weeks of pregnancy (17.8%), Յ12 years of education (55.7%), a history of chlamydia (6.1%), and not being married (5.7%) (data not shown).
DISCUSSION
Our primary finding is that prior UTIs (both before pregnancy and particularly during the first 20 weeks of the current pregnancy) are predictive of symptomatic UTI after 20 weeks' gestation. UTIs after prenatal care initiation during the first 20 weeks of pregnancy appear to be a stronger risk factor than antenatal UTIs before prenatal care or UTIs before pregnancy. Data to examine the timing of infection in detail were not available, however. Although this finding may have been anticipated, to our knowledge, this is only the second report 15 to examine the association between pre-pregnancy history of UTI and pyelonephritis, and the first report to examine the risk from antepartum UTIs before prenatal care initiation.
Several studies of symptomatic antepartum UTI have reported at least a 50% increased incidence among women with sickle hemoglobin, 9, 26, 27 but these investigations were restricted to exclusively black populations. Other researchers reported both lower, 7 higher, 3 and the same 12,28 frequency of bacteriuria/UTI among blacks compared with other races, although they did not assess hemoglobinopathies. One recent investigation with this same cohort found that black sickle cell-positive women had a higher prevalence of bacteriuria at the first prenatal visit than white women, who in turn had slightly higher prevalence than black women with normal hemoglobin. 17 In this report, we separated the correlated race and sickle cell disease/trait effects for symptomatic UTIs later in pregnancy. Our models suggested a 50% to 90% increased risk associated with sickle cell hemo- globin after adjustment for race. We found a modest, nonsignificant, excess of all symptomatic UTIs combined among black women, controlling for sickle cell hemoglobinopathy. Socioeconomic status (SES), as measured by public or private hospital of delivery, was theorized to be associated with antenatal bacteriuria and UTI. 8 Three other reports, all conducted in the United Kingdom, attempted to evaluate the role of SES: one reported a positive association between lower social class and ASB at the first prenatal visit after controlling for age and parity, 13 the second found higher unadjusted prevalences of bacteriuria at the first prenatal visit for both the highest and lowest social classes (a u-shaped relation), 29 and the third found no association. 30 We analyzed several factors (location of care, race, marital status, education, and maternal employment) both as surrogate measures of SES and as individual predictors. Overall, our results tend not to support an association between SES and all symptomatic UTIs combined, whereas our pyelonephritis analysis does imply an association with SES. Those attending nonprivate clinics had an increased incidence of symptomatic UTI after controlling for all other variables. Marital status, education, and maternal employment did not display an association with symptomatic UTIs in total; however, unmarried women and those with Յ12 years of education were at increased risk of pyelonephritis. Al-Sabai 14 found no association with education, and no relevant literature on the other two factors was located.
Although no exact comparison was available from the literature, a prior study of bacteriuria/UTI during pregnancy found an OR of 2.1 associated with genital tract infections at any time during pregnancy. 3 This result is consistent with our finding of increased risk in relation to STDs and vaginal infections, especially chlamydia, whereas vaginal flora was reported to have no association with bacteriuria assessed at the first prenatal visit. 6 The ϳ50% lower incidence of antepartum cystitis at DUMC/DRH compared with UNCH deserves comment. Three possible explanations are (1) different diagnostic procedures, (2) different patient populations, and (3) data-recording variation. The diagnostic method was not available for all cases; thus, we cannot address the first possible explanation. The second explanation requires that the DUMC/DRH population be less likely to have risk factor(s) for cystitis than the UNCH population. Comparison of the prevalences of these factors by hospital and their association with cystitis failed to support this theory. Last, comparison between a random sample of medical charts and the computerized databases found the accuracy of the UNCH database to be greater than the DUMC/DRH database for antepartum UTI diagnoses as measured by kappa statistics of 0.80 and 0.48, respectively. 17 (Note that, due to the data cleaning efforts reviewed earlier, the data used in our models are of higher quality than these statistics imply.) In summary, the differences by hospital in the cumulative incidence of cystitis are partly explained by data quality differences in the computer records.
There are several limitations to this study. Disease misclassification is possible because not all infections were confirmed with culture, episodes may not have been recorded in the computer systems and/or charts, and episodes may have received care outside the prenatal care clinic. No bias would be expected from disease under-ascertainment if it is nondifferential with respect to the potential risk factors. 31 Different screening protocols between medical facilities may also cause some bias, although the fact that inclusion of the few ASB cases had a minimal effect on the results provides some evidence that any diagnostic bias would be small. More frequent screening or aggressive treatment of some women (e.g., those with sickle cell hemoglobinopathy) may bias our retrospective results toward more diagnoses of asymptomatic and moderately symptomatic UTIs, thus perpetuating results that show such a group to be at increased risk for ASB/cystitis. The results are also limited by the data fields contained in the computer files. It would have been of interest to consider coital frequency and body mass index, for example.
There are two notable strengths of this study relative to previous studies. First is the identification of demographic and medical history risk factors for pyelonephritis. Although there is extensive literature on the impact of screening and treatment strategies of bacteriuria at the first prenatal care visit on progression to pyelonephritis, research since 1960 on the risk factors for pyelonephritis other than history of UTI appears limited to one report on race 7 and a few reports on sickle cell hemoglobin among exclusively black populations. 9, 26, 27 Second, the examination of predictors of symptomatic UTI during the latter portion of pregnancy enhances the clinical relevance of the research because of the more serious sequelae of infections in this time period.
Additional study strengths include investigation of topics either never explored for symptomatic UTIs (e.g., alcohol, smoking, and illicit drug use) or only infrequently analyzed (e.g., education, antepartum vaginal infections). Improved statistical and epidemiologic methods were used; only one of the relevant studies 3 used multivariate techniques, and that report was not restricted to symptomatic infections. Based on Medline literature reviews, this study is the second largest to address maternal risk factors for antepartum UTI (second to Schieve et al. 3 ). Moreover, by studying a sociodemographically diverse area, we were able to examine a range of potential risk factors, including the effect of black race separate from sickle cell hemoglobin. These results can be used to design a clinic protocol based on risk factors known at prenatal care initiation and those reflecting the woman's medical history during the first 20 weeks of pregnancy. In some women, it may be worthwhile to screen for bacteriuria a second time, in addition to the universal screening at the first prenatal visit. We estimate that ϳ200,000 cases of cystitis and pyelonephritis combined are diagnosed annually in the United States after the first prenatal care visit. Given the medical attention required for antenatal pyelonephritis and its sequelae for maternal and infant health, prospective research is warranted to confirm and identify additional maternal risk factors and to evaluate the impact of targeted, antepartum screening on the incidence of subsequent symptomatic infections.
